Related references
Note: Only part of the references are listed.Chiral polypeptide nanoparticles as nanoadjuvants of nanovaccines for efficient cancer prevention and therapy
Yuanzhen Su et al.
SCIENCE BULLETIN (2023)
Engineered bacteria combined with doxorubicin nanoparticles suppress angiogenesis and metastasis in murine melanoma models
Meiyang Yang et al.
ACTA BIOMATERIALIA (2023)
Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy
Xupeng Yang et al.
ACS NANO (2022)
Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy
Wenbo Han et al.
BIOMATERIALS (2022)
Antihistamines for cancer immunotherapy: More than just treating allergies
Song Chen et al.
CANCER CELL (2022)
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li et al.
CANCER CELL (2022)
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
Amir R. Afshari et al.
SEMINARS IN CANCER BIOLOGY (2022)
Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer
Fang Yuan et al.
THERANOSTICS (2022)
Engineered Bacteria Enhance Immunotherapy and Targeted Therapy through Stromal Remodeling of Tumors
Shindu C. Thomas et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Development of a Localized Drug Delivery System with a Step-by-Step Cell Internalization Capacity for Cancer Immunotherapy
Xilin Li et al.
ACS NANO (2022)
Tumor microcalcification-me diate d relay drug delivery for photodynamic immunotherapy of breast cancer
Hui Jian et al.
ACTA BIOMATERIALIA (2022)
TRAIL-modifie d, doxorubicin-emb e dde d periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy
Xinyao Feng et al.
ACTA BIOMATERIALIA (2022)
A Tumor Microenvironments-Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and Immunoactivation
Zhongmin Li et al.
ADVANCED MATERIALS (2022)
Recruitment of dendritic cells using 'find-me' signaling microparticles for personalized cancer immunotherapy
Jae Ah Lee et al.
BIOMATERIALS (2022)
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Yared Hailemichael et al.
CANCER CELL (2022)
Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
Nathan E. Reticker-Flynn et al.
CELL (2022)
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer-The PICCASSO phase I trial
Georg Martin Haag et al.
EUROPEAN JOURNAL OF CANCER (2022)
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
Maxime Meylan et al.
IMMUNITY (2022)
Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Tumour Progression in the Regenerating Liver Following Partial Hepatectomy
Georgina E. Riddiough et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents
Clare Murray et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial
Federica Morano et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment
Chen Li et al.
FRONTIERS IN IMMUNOLOGY (2022)
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model
Roxanne Wouters et al.
PHARMACEUTICS (2022)
CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment
Tingwei Lu et al.
JOURNAL OF EXTRACELLULAR VESICLES (2022)
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
Adrienne M. Luoma et al.
CELL (2022)
Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung Cancer
Antonio Passaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8+ T Cells for Enhanced IFNγ Production by Metformin
Ruoyu Chao et al.
FRONTIERS IN IMMUNOLOGY (2022)
Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery
Mukrime Birgul Akolpoglu et al.
SCIENCE ADVANCES (2022)
Single-cell technologies: From research to application
Lu Wen et al.
INNOVATION (2022)
Carbidopa, an activator of aryl hydrocarbon receptor, suppresses IDO1 expression in pancreatic cancer and decreases tumor growth
Ksenija Korac et al.
BIOCHEMICAL JOURNAL (2022)
Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
Agnieszka Chryplewicz et al.
CANCER CELL (2022)
Sinomenine promotes differentiation of induced pluripotent stem cells into immature dendritic cells with high induction of immune tolerance
Xiao-Yan Huang et al.
WORLD JOURNAL OF STEM CELLS (2022)
Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications
Carlos Wagner S. Wanderley et al.
FRONTIERS IN IMMUNOLOGY (2022)
Single-cell technologies: From research to application
Lu Wen et al.
INNOVATION-THE EUROPEAN JOURNAL OF SOCIAL SCIENCE RESEARCH (2022)
Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy
Xiangru Feng et al.
SCIENCE BULLETIN (2021)
Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities
Sepideh Nezhadi et al.
JOURNAL OF DRUG TARGETING (2021)
The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells
Lina Song et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial
B. G. M. Hughes et al.
ANNALS OF ONCOLOGY (2021)
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
M. Shi et al.
ANNALS OF ONCOLOGY (2021)
Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs
In Seon Jeon et al.
BIOMATERIALS (2021)
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
Egle Ramelyte et al.
CANCER CELL (2021)
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
Yunfan Sun et al.
CELL (2021)
Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma
Minsu Kwon et al.
CANCER LETTERS (2021)
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Paula M. Cevaal et al.
ACS NANO (2021)
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC
Jyoti Malhotra et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Ultrasound-Augmented Mitochondrial Calcium Ion Overload by Calcium Nanomodulator to Induce Immunogenic Cell Death
Pan Zheng et al.
NANO LETTERS (2021)
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
Thomas Powles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Pan-cancer single cell landscape of tumor-infiltrating T cells
Liangtao Zheng et al.
SCIENCE (2021)
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer
Christopher A. Chuckran et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery
Xudong Hu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells
Hannah S. Newton et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma
Mehreen Ishfaq et al.
CANCERS (2021)
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Aukie Hooglugt et al.
FRONTIERS IN ONCOLOGY (2021)
Transformable Nanosensitizer with Tumor Microenvironment-Activated Sonodynamic Process and Calcium Release for Enhanced Cancer Immunotherapy
Xuan Tan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
Akemi Kosaka et al.
CANCER SCIENCE (2021)
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
Nehal Gupta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Tissue-resident memory T cells in tumor immunity and immunotherapy
Karolina Okla et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy
Baicheng Wei et al.
NANO LETTERS (2021)
Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment
Yunkai Yang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy
Xiuman Zhou et al.
BIOMOLECULES (2021)
Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis
Shichuan Hu et al.
ACTA BIOMATERIALIA (2021)
Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy
Yupeng Wang et al.
ADVANCED MATERIALS (2021)
Amlexanox enhances the antitumor effect of anti-PD-1 antibody
Kazuhiko Takeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Repurposing macitentan with nanoparticle modulates tumor microenvironment to potentiate immune checkpoint blockade
Soyoung Son et al.
BIOMATERIALS (2021)
Drug repurposing: Iron in the fire for older drugs
H. V. Sonaye et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
Sydney X. Lu et al.
CELL (2021)
Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells
Fan-Jie Meng et al.
IMMUNOLOGY LETTERS (2021)
Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy
Huan Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors
Bai Liu et al.
MOLECULAR THERAPY (2021)
Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition
Mohammad Taleb et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
Daniel A. Rauch et al.
NANOMATERIALS (2021)
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer The REACT Randomized Clinical Trial
R. Charles Coombes et al.
JAMA ONCOLOGY (2021)
Depression Induced by CUMS Leads to Bladder Cancer Development and Local Tumor Immunosuppression in Mice
Zhiyu Qian et al.
JOURNAL OF ONCOLOGY (2021)
Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
Haley du Bois et al.
SCIENCE IMMUNOLOGY (2021)
Insights Into Unveiling a Potential Role of Tertiary Lymphoid Structures in Metastasis
Rami Mustapha et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma
Binita Chakraborty et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling
Jiale An et al.
ONCOIMMUNOLOGY (2021)
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens
Andrew S. Truong et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
Hanchen Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy
Angel Charles et al.
ONCOIMMUNOLOGY (2021)
Collagenase-loaded pH-sensitive nanocarriers efficiently remodeled tumor stroma matrixes and improved the enrichment of nanomedicines
Jiading Wang et al.
NANOSCALE (2021)
HSP90 Inhibition Enhances Cancer Immunotherapy by Modulating the Surface Expression of Multiple Immune Checkpoint Proteins
Reza Beheshti Zavareh et al.
CELL CHEMICAL BIOLOGY (2021)
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs
Cesar Oyarce et al.
ONCOIMMUNOLOGY (2021)
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial
George W. Sledge et al.
JAMA ONCOLOGY (2020)
LINCS Data Portal 2.0: next generation access point for perturbation-response signatures
Vasileios Stathias et al.
NUCLEIC ACIDS RESEARCH (2020)
Tumor Microenvironment, Metabolism, and Immunotherapy
Ralph J. DeBerardinis
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H. Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance
Mohamed A. ElTanbouly et al.
SCIENCE (2020)
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Candice R. Gurbatri et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Gold Nanoparticles Induce Tumor Vessel Normalization and Impair Metastasis by Inhibiting Endothelial Smad2/3 Signaling
Na Huang et al.
ACS NANO (2020)
Gd-metallofullerenol drug delivery system mediated macrophage polarization enhances the efficiency of chemotherapy
Jinglong Tang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic
Tao Sun et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Zwitterionic Nanoconjugate Enables Safe and Efficient Lymphatic Drug Delivery
Bowen Li et al.
NANO LETTERS (2020)
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis
Fabio Gelsomino et al.
CANCERS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration
David Kolb et al.
ACS NANO (2020)
Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation
Cheng-Ying Wu et al.
JOURNAL OF IMMUNOLOGY (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles
Jiayan Wu et al.
SCIENCE ADVANCES (2020)
Recombinant Human Thyroid-Stimulating Hormone Increases the Percentages of Natural Killer T Cells and B Lymphocytes in Human Peripheral Blood In Vivo
Zbigniew Adamczewski et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery
Sergio Andres Torres-Perez et al.
FRONTIERS IN ONCOLOGY (2020)
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity
Myrofora Panagi et al.
THERANOSTICS (2020)
Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine
Yuma Yamada et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy
Xueying Tang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner
Qian-Feng Zhang et al.
THERANOSTICS (2020)
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2019)
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Ivy X. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Mutational anc Anticenic Lancsca Tumor Procression anc Cancer Immunotheraoy
Ilio Vitale et al.
TRENDS IN CELL BIOLOGY (2019)
Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
Xingzhe Ma et al.
CELL METABOLISM (2019)
Cytokine Therapy
Ann W. Silk et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade
Brian P. Riesenberg et al.
JOURNAL OF IMMUNOLOGY (2019)
IFN-γ: A cytokine at the right time, is in the right place
J. Daniel Burke et al.
SEMINARS IN IMMUNOLOGY (2019)
Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy
Bing Feng et al.
ADVANCED MATERIALS (2019)
Hypoxia-Triggered Transforming Immunomodulator for Cancer Immunotherapy via Photodynamically Enhanced Antigen Presentation of Dendritic Cell
Sooseok Im et al.
ACS NANO (2019)
Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw
Weiwen Zhu et al.
FASEB JOURNAL (2019)
Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
Wenquan Ou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Aspirin Disrupts the Crosstalk of Angiogenic and Inflammatory Cytokines between 4T1 Breast Cancer Cells and Macrophages
Chia-Chien Hsieh et al.
MEDIATORS OF INFLAMMATION (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
Magdalena Jarosz-Biej et al.
PLOS ONE (2018)
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
David A. Schaer et al.
CELL REPORTS (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Targeting minimal residual disease: a path to cure?
Marlise R. Luskin et al.
NATURE REVIEWS CANCER (2018)
Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy
Natalia N. Ferreira et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Ibrutinib treatment improves T cell number and function in CLL patients
Meixiao Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Repurposing ospemifene for potentiating an antigen-specific immune response
Chiao-Jung Kao et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Chloroquine attenuates TLR3/IFN- signaling in cultured normal human mesangial cells: A possible protective effect against renal damage in lupus nephritis
Tadaatsu Imaizumi et al.
MODERN RHEUMATOLOGY (2017)
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Giovanni Germano et al.
NATURE (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner
Panagiotis Papageorgis et al.
SCIENTIFIC REPORTS (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Synergistic Suppression of Tumor Angiogenesis by the Co-delivering of Vascular Endothelial Growth Factor Targeted siRNA and Candesartan Mediated by Functionalized Carbon Nanovectors
Xuefang Ding et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Chayanon Ngambenjawong et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Synchronized cycles of bacterial lysis for in vivo delivery
M. Omar Din et al.
NATURE (2016)
AIRE expands: new roles in immune tolerance and beyond
Mark S. Anderson et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance
Hanyu Zeng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
New Developments in Liposomal Drug Delivery
Bhushan S. Pattni et al.
CHEMICAL REVIEWS (2015)
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
Ignazio Caruana et al.
NATURE MEDICINE (2015)
Ganetespib: research and clinical development
Komal Jhaveri et al.
ONCOTARGETS AND THERAPY (2015)
The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies
Akinori Sato
ONCOTARGETS AND THERAPY (2015)
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells
Astrid Authier et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Paradoxic effects of metformin on endothelial cells and angiogenesis
Katiuscia Dallaglio et al.
CARCINOGENESIS (2014)
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
Seung Tae Kim et al.
EUROPEAN JOURNAL OF CANCER (2014)
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Jedd D. Wolchok et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012 (2013)
In Vivo Targeting of Intratumor Regulatory T Cells Using PEG-Modified Single-Walled Carbon Nanotubes
Cristiano Sacchetti et al.
BIOCONJUGATE CHEMISTRY (2013)
Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles
Qiu Guo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Rapid Copper Acquisition by Developing Murine Mesothelioma: Decreasing Bioavailable Copper Slows Tumor Growth, Normalizes Vessels and Promotes T Cell Infiltration
Andrew Crowe et al.
PLOS ONE (2013)
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Laurie Menger et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Applications of Functionalized Fullerenes in Tumor Theranostics
Zhiyun Chen et al.
THERANOSTICS (2012)
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer
Holger Bronger et al.
BREAST CANCER RESEARCH (2012)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation
Jarish N. Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
Paola Nistico et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
Gabrielle A. Rizzuto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma
S Brem et al.
NEURO-ONCOLOGY (2005)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Copper control as an antiangiogenic anticancer therapy: Lessons from treating Wilson's disease
GJ Brewer
EXPERIMENTAL BIOLOGY AND MEDICINE (2001)